1. Home
  2. KRT vs ANL Comparison

KRT vs ANL Comparison

Compare KRT & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karat Packaging Inc.

KRT

Karat Packaging Inc.

N/A

Current Price

$54.23

Market Cap

957.7M

Sector

Industrials

ML Signal

N/A

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$15.91

Market Cap

998.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRT
ANL
Founded
2000
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
957.7M
998.8M
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
KRT
ANL
Price
$54.23
$15.91
Analyst Decision
Sell
Strong Buy
Analyst Count
2
1
Target Price
★ $26.50
$20.00
AVG Volume (30 Days)
132.3K
★ 156.7K
Earning Date
05-07-2026
04-10-2026
Dividend Yield
★ 6.33%
N/A
EPS Growth
★ 4.70
N/A
EPS
★ 1.80
N/A
Revenue
★ $467,743,000.00
N/A
Revenue This Year
$13.05
$36.02
Revenue Next Year
$8.11
N/A
P/E Ratio
$30.09
★ N/A
Revenue Growth
★ 10.67
N/A
52 Week Low
$20.61
$0.88
52 Week High
$54.67
$17.25

Technical Indicators

Market Signals
Indicator
KRT
ANL
Relative Strength Index (RSI) 73.03 58.07
Support Level $22.79 $12.07
Resistance Level N/A $17.25
Average True Range (ATR) 1.83 1.16
MACD 0.35 0.02
Stochastic Oscillator 89.67 55.73

Price Performance

Historical Comparison
KRT
ANL

About KRT Karat Packaging Inc.

Karat Packaging Inc is a distributor and manufacturer of disposable foodservice products and related items, including containers, bags, tableware, cups, lids, cutlery, straws, specialty beverage ingredients, gloves, and janitorial supplies, available in plastic, paper, biopolymer-based, and other compostable forms. The Company focuses on environmentally friendly products and provides customized solutions including product development, design, printing, and logistics services. It serves customers through chains and distributors, retail, and e-commerce/online, and operates in the manufacturing and distribution of single-use food and beverage products, as well as specialty food and beverage products and restaurant and warehouse supplies.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

Share on Social Networks: